Reims, France

Bernard Chistrophe Barlaam


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Bernard Chistrophe Barlaam

Introduction

Bernard Chistrophe Barlaam is a notable inventor based in Reims, France. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on chromenone derivatives. His research and inventions have the potential to impact the treatment of various cell proliferative disorders.

Latest Patents

Barlaam holds a patent for chromenone derivatives, which includes a formula for pharmaceutically acceptable salts. This invention outlines processes for the preparation of these derivatives, pharmaceutical compositions containing them, and their application in the manufacture of medicaments aimed at treating cell proliferative disorders. His patent represents a significant advancement in pharmaceutical chemistry.

Career Highlights

Barlaam is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to the development of innovative treatments that address critical health issues. His expertise in the field has been recognized through his patent and ongoing research efforts.

Collaborations

Throughout his career, Barlaam has collaborated with esteemed colleagues such as Sebastien Louis Degorce and Christine Marie Paul Lambert-Van Der Brempt. These collaborations have fostered a productive environment for innovation and have led to advancements in their respective fields.

Conclusion

Bernard Chistrophe Barlaam's contributions to the field of pharmaceuticals through his patent on chromenone derivatives highlight his role as an influential inventor. His work continues to pave the way for new treatments in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…